NCT03615768 - A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

1,617

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

February 13, 2020

Study Completion Date

April 7, 2020

Conditions

Acne Vulgaris

Interventions

COMBINATION_PRODUCT

Adapalene-Clindamycin Combination Gel

5mg Adapalene/50mg Clindamycin per 5g, applied nightly for 12 weeks

DRUG

Adapalene Gel

Differin 0.1% Gel, applied nightly for 12 weeks

DRUG

Clindamycin Gel

Clindamycin Phosphate 1% Gel applied twice daily for 12 weeks

Trial Locations (1)

Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing